Imagion Biosystems hits key development milestone with initiation of toxicology study
Imagion Biosystems has achieved a key milestone in its progress to first-in-human testing with the commencement of a toxicology safety study of its lead…
Investor Update — Corporate Presentation Visuals
Imagion Biosystems has updated investors by lodging the latest version of its corporate presentation visuals with the Australian Securities Exchange. Content…
Company Overview Presentation
click image to download pdf file Here are the principal "slide deck" visuals used to introduce Imagion Biosystems to investors prior to the company's initial…